Bates GP - Search Results

1

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington's disease mice.

Bondulich MK, Jolinon N, Osborne GF, Smith EJ, Rattray I, Neueder A, Sathasivam K, Ahmed M, Ali N, Benjamin AC, Chang X, Dick JRT, Ellis M, Franklin SA, Goodwin D, Inuabasi L, Lazell H, Lehar A, Richard-Londt A, Rosinski J, Smith DL, Wood T, Tabrizi SJ, Brandner S, Greensmith L, Howland D, Munoz-Sanjuan I, Lee SJ, Bates GP. Bondulich MK, et al. Among authors: bates gp. Sci Rep. 2017 Oct 27;7(1):14275. doi: 10.1038/s41598-017-14290-3. Sci Rep. 2017. PMID: 29079832 Free PMC article.

2

Exon 1 of the HD gene with an expanded CAG repeat is sufficient to cause a progressive neurological phenotype in transgenic mice.

Mangiarini L, Sathasivam K, Seller M, Cozens B, Harper A, Hetherington C, Lawton M, Trottier Y, Lehrach H, Davies SW, Bates GP. Mangiarini L, et al. Among authors: bates gp. Cell. 1996 Nov 1;87(3):493-506. doi: 10.1016/s0092-8674(00)81369-0. Cell. 1996. PMID: 8898202 Free article.

3

Instability of highly expanded CAG repeats in mice transgenic for the Huntington's disease mutation.

Mangiarini L, Sathasivam K, Mahal A, Mott R, Seller M, Bates GP. Mangiarini L, et al. Among authors: bates gp. Nat Genet. 1997 Feb;15(2):197-200. doi: 10.1038/ng0297-197. Nat Genet. 1997. PMID: 9020849

4

Identification of an HD patient with a (CAG)180 repeat expansion and the propagation of highly expanded CAG repeats in lambda phage.

Sathasivam K, Amaechi I, Mangiarini L, Bates G. Sathasivam K, et al. Hum Genet. 1997 May;99(5):692-5. doi: 10.1007/s004390050432. Hum Genet. 1997. PMID: 9150744

5

Aberrant processing of the Fugu HD (FrHD) mRNA in mouse cells and in transgenic mice.

Sathasivam K, Baxendale S, Mangiarini L, Bertaux F, Hetherington C, Kanazawa I, Lehrach H, Bates GP. Sathasivam K, et al. Among authors: bates gp. Hum Mol Genet. 1997 Nov;6(12):2141-9. doi: 10.1093/hmg/6.12.2141. Hum Mol Genet. 1997. PMID: 9328479

6

HAP1-huntingtin interactions do not contribute to the molecular pathology in Huntington's disease transgenic mice.

Bertaux F, Sharp AH, Ross CA, Lehrach H, Bates GP, Wanker E. Bertaux F, et al. Among authors: bates gp. FEBS Lett. 1998 Apr 17;426(2):229-32. doi: 10.1016/s0014-5793(98)00352-4. FEBS Lett. 1998. PMID: 9599014 Free article.

7

Formation of polyglutamine inclusions in non-CNS tissue.

Sathasivam K, Hobbs C, Turmaine M, Mangiarini L, Mahal A, Bertaux F, Wanker EE, Doherty P, Davies SW, Bates GP. Sathasivam K, et al. Among authors: bates gp. Hum Mol Genet. 1999 May;8(5):813-22. doi: 10.1093/hmg/8.5.813. Hum Mol Genet. 1999. PMID: 10196370

8

Transgenic models of Huntington's disease.

Sathasivam K, Hobbs C, Mangiarini L, Mahal A, Turmaine M, Doherty P, Davies SW, Bates GP. Sathasivam K, et al. Among authors: bates gp. Philos Trans R Soc Lond B Biol Sci. 1999 Jun 29;354(1386):963-9. doi: 10.1098/rstb.1999.0447. Philos Trans R Soc Lond B Biol Sci. 1999. PMID: 10434294 Free PMC article. Review.

9

Mitochondrial dysfunction and free radical damage in the Huntington R6/2 transgenic mouse.

Tabrizi SJ, Workman J, Hart PE, Mangiarini L, Mahal A, Bates G, Cooper JM, Schapira AH. Tabrizi SJ, et al. Ann Neurol. 2000 Jan;47(1):80-6. doi: 10.1002/1531-8249(200001)47:1<80::aid-ana13>3.3.co;2-b. Ann Neurol. 2000. PMID: 10632104

10

Centrosome disorganization in fibroblast cultures derived from R6/2 Huntington's disease (HD) transgenic mice and HD patients.

Sathasivam K, Woodman B, Mahal A, Bertaux F, Wanker EE, Shima DT, Bates GP. Sathasivam K, et al. Among authors: bates gp. Hum Mol Genet. 2001 Oct 1;10(21):2425-35. doi: 10.1093/hmg/10.21.2425. Hum Mol Genet. 2001. PMID: 11689489

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

250 results

Search Page

Filters